110 related articles for article (PubMed ID: 20662682)
1. Swedish clinical guidelines--prevention and management of metabolic risk in patients with severe psychiatric disorders.
Gothefors D; Adolfsson R; Attvall S; Erlinge D; Jarbin H; Lindström K; von Hausswolff-Juhlin YL; Morgell R; Toft E; Osby U;
Nord J Psychiatry; 2010 Oct; 64(5):294-302. PubMed ID: 20662682
[TBL] [Abstract][Full Text] [Related]
2. Prevention of metabolic syndrome in serious mental illness.
Ganguli R; Strassnig M
Psychiatr Clin North Am; 2011 Mar; 34(1):109-25. PubMed ID: 21333843
[TBL] [Abstract][Full Text] [Related]
3. Outcome evaluation of a structured educational wellness program in patients with severe mental illness.
Lindenmayer JP; Khan A; Wance D; Maccabee N; Kaushik S; Kaushik S
J Clin Psychiatry; 2009 Oct; 70(10):1385-96. PubMed ID: 19778494
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome: epidemiology and consequences.
Sacks FM
J Clin Psychiatry; 2004; 65 Suppl 18():3-12. PubMed ID: 15600380
[TBL] [Abstract][Full Text] [Related]
5. Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications.
Hasnain M; Vieweg WV; Fredrickson SK; Beatty-Brooks M; Fernandez A; Pandurangi AK
Prim Care Diabetes; 2009 Feb; 3(1):5-15. PubMed ID: 19083283
[TBL] [Abstract][Full Text] [Related]
6. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
Battista M; Murray RD; Daniels SR
Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness.
Vergara-Rodriguez P; Vibhakar S; Watts J
Pharmacol Ther; 2009 Dec; 124(3):269-78. PubMed ID: 19647020
[TBL] [Abstract][Full Text] [Related]
8. Management of schizophrenia with obesity, metabolic, and endocrinological disorders.
Monteleone P; Martiadis V; Maj M
Psychiatr Clin North Am; 2009 Dec; 32(4):775-94. PubMed ID: 19944883
[TBL] [Abstract][Full Text] [Related]
9. Recent Swedish clinical practice guidelines for prevention and management of metabolic risk.
de Hert M
Nord J Psychiatry; 2010 Oct; 64(5):291-2. PubMed ID: 20840009
[No Abstract] [Full Text] [Related]
10. Implementation of monitoring and management guidelines for second-generation antipsychotics.
Sernyak MJ
J Clin Psychiatry; 2007; 68 Suppl 4():14-8. PubMed ID: 17539695
[TBL] [Abstract][Full Text] [Related]
11. Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics.
Park T; Usher K; Foster K
Int J Ment Health Nurs; 2011 Dec; 20(6):428-37. PubMed ID: 21564457
[TBL] [Abstract][Full Text] [Related]
12. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
Schneiderhan ME; Batscha CL; Rosen C
Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and mental illness.
Newcomer JW
Am J Manag Care; 2007 Nov; 13(7 Suppl):S170-7. PubMed ID: 18041878
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
Misra A; Khurana L
Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
[TBL] [Abstract][Full Text] [Related]
15. Bridging the gap from evidence to policy and practice: reducing the progression to metabolic syndrome for children and adolescents on antipsychotic medication.
Eapen V; Shiers D; Curtis J
Aust N Z J Psychiatry; 2013 May; 47(5):435-42. PubMed ID: 23047958
[TBL] [Abstract][Full Text] [Related]
16. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective.
Compton MT; Daumit GL; Druss BG
Harv Rev Psychiatry; 2006; 14(4):212-22. PubMed ID: 16912007
[TBL] [Abstract][Full Text] [Related]
18. Slaying the metabolic syndrome. Are we battling the Hydra or the Chimera?
Dunbar RL; Rader DJ
Minerva Endocrinol; 2004 Sep; 29(3):89-111. PubMed ID: 15282443
[TBL] [Abstract][Full Text] [Related]
19. Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes.
Edward KL; Rasmussen B; Munro I
Arch Psychiatr Nurs; 2010 Feb; 24(1):46-53. PubMed ID: 20117688
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
Rege S
Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
